Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: SCYNEXIS Inc., 3 years.
SCYNEXIS Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | SCYNEXIS Inc. | Grant or award | +2,875 | — | — |
| Jun 26, 2025 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Feb 14, 2025 | Arbutus Biopharma Corporation | Grant or award | +90,100 | — | — |
| Feb 4, 2025 | Arbutus Biopharma Corporation | Open-market sale | −22,183 | $3.28 | $72,760 |
| Jun 20, 2024 | SCYNEXIS Inc. | Grant or award | +23,000 | — | — |
| Feb 2, 2024 | Arbutus Biopharma Corporation | Open-market sale | −9,593 | $2.31 | $22,160 |
| Feb 1, 2024 | Arbutus Biopharma Corporation | Grant or award | +112,500 | — | — |
| Jun 15, 2023 | SCYNEXIS Inc. | Grant or award | +10,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.